Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyi Meng

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 14, 2021
Deoxynivalenol photocatalytic detoxification products alleviate intestinal barrier damage and gut flora disorder in BLAB/c miceYou Zhou, Shuo Qi, Xiangyi Meng, et al.
Foods (Basel, Switzerland)|November 9, 2024
Simulation Analysis of 3-D Airflow and Temperature Uniformity of Paddy in a Laboratory Drying OvenChangzhi Wang, Yongsheng Pei, Zhongqiu Mu, et al.
The Journal of Dermatological Treatment|August 20, 2016
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasisApril W Armstrong, Steven R Feldman, Neil J Korman, et al.
Magnetic Resonance in Medicine|February 23, 2021
Diffusion interactions between crossing fibers of the brainSergey V Buldyrev, Xiangyi Meng, Timothy G Reese, et al.
Dermatology and Therapy|December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 StudiesDavid Pariser, Ellen Frankel, Joel Schlessinger, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) studyMarcelo Kremenchutzky, Paul O'Connor, Reinhard Hohlfeld, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its ReparationZheng Huang, Tong Xian, Xiangyi Meng, et al.
Clinical Schizophrenia & Related Psychoses|November 5, 2014
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophreniaLeslie Citrome, Peter J Weiden, Gus Alva, et al.
The Journal of Dermatological Treatment|October 7, 2020
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trialsAlice B Gottlieb, Jashin J Wu, Christopher E M Griffiths, et al.
Ophthalmology|November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized TrialRobert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 14, 2021
Deoxynivalenol photocatalytic detoxification products alleviate intestinal barrier damage and gut flora disorder in BLAB/c miceYou Zhou, Shuo Qi, Xiangyi Meng, et al.
Foods (Basel, Switzerland)|November 9, 2024
Simulation Analysis of 3-D Airflow and Temperature Uniformity of Paddy in a Laboratory Drying OvenChangzhi Wang, Yongsheng Pei, Zhongqiu Mu, et al.
The Journal of Dermatological Treatment|August 20, 2016
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasisApril W Armstrong, Steven R Feldman, Neil J Korman, et al.
Magnetic Resonance in Medicine|February 23, 2021
Diffusion interactions between crossing fibers of the brainSergey V Buldyrev, Xiangyi Meng, Timothy G Reese, et al.
Dermatology and Therapy|December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 StudiesDavid Pariser, Ellen Frankel, Joel Schlessinger, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) studyMarcelo Kremenchutzky, Paul O'Connor, Reinhard Hohlfeld, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its ReparationZheng Huang, Tong Xian, Xiangyi Meng, et al.
Clinical Schizophrenia & Related Psychoses|November 5, 2014
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophreniaLeslie Citrome, Peter J Weiden, Gus Alva, et al.
The Journal of Dermatological Treatment|October 7, 2020
Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trialsAlice B Gottlieb, Jashin J Wu, Christopher E M Griffiths, et al.
Ophthalmology|November 8, 2018
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized TrialRobert N Weinreb, Jason Bacharach, Robert D Fechtner, et al.
Pageof 14